MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits (original) (raw)

• Matrisian LM. Metalloproteinases and their inhibitors in tissue remodeling. Trends Genet 1990; 6: 121–5.
  Article PubMed CAS Google Scholar
• Testa JE, Quigley JP. The role of urokinase-type plasminogen activator in aggressive tumour cell behavior. Cancer Metastasis Rev 1990; 9: 353–67.
  Article PubMed CAS Google Scholar
• Sloane BF, Moin K, Lah TT. Regulation of lysosomal endopeptidases in malignant neoplasia. In Pretlow TG and Pretlow TP (eds): Biochemical and Molecular Aspects of Selected Cancers. New York: Academic Press 1994; Vol. 2; 411–66.
  Google Scholar
• Terranova VP, Hujanen ES, Martin GR. Basement membrane and the invasive activity of metastatic tumour cells. J Natl Cancer Inst 1986; 77: 311–6.
  PubMed CAS Google Scholar
• Basset P, Bellocq JP, Wolf C et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (London) 1990; 348: 699–704.
  Article CAS Google Scholar
• Pyke C, Ralfkiaer E, Tryggvason K et al. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993; 142: 359–65.
  PubMed CAS Google Scholar
• Heppner KJ, Matrisian LM, Jensen RA et al. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor induced host response. Am J Pathol 1996; 149: 273–82.
  PubMed CAS Google Scholar
• Nielsen BS, Timshel S, Kjeldsen L et al. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in human colon cancer. Int J Cancer 1996; 65: 57–62.
  Article PubMed CAS Google Scholar
• Gilles C, Thompson EW. The epithelial to mesenchymal transition and metastatic progession in carcinomas. Breast J 1996; 2: 83–96.
  Google Scholar
• Yoneda T, Sasaki A, Mundy GR. Osteolytic bone metastasis in breast cancer. Breast Cancer Res 1994; 32: 73–84.
  Article CAS Google Scholar
• Miller BE, Roi LD, Howard LM, Miller FR. Quantitative selectivity of contact mediated intercellular communication in a metastatic mouse mammary tumor line. Cancer Res 1983; 43: 4102–7.
  PubMed CAS Google Scholar
• Lelekakis M, Moseley JM, Martin TJ et al. A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 1999; 17: 163–70.
  Article PubMed CAS Google Scholar
• Sung V, Cattell DA, Bueno JM et al. Human breast cancer cell metastasis to long bone and soft organs of nude mice: A quantitative assay. Clin Exp Metastasis 1997; 15: 173–82.
  Article PubMed CAS Google Scholar
• Kjonniksen I, Winderen M, Brunland O et al. Validity and usefulness of human tumor models established by intratibial cell inoculation in nude rats. Cancer Res 1994; 54: 1715–9.
  PubMed CAS Google Scholar
• Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992; 52: 1399–405.
  PubMed CAS Google Scholar
• Yu M. Sato H. Seiki M. et al. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 1995; 55: 3272–7.
  PubMed CAS Google Scholar
• Sato H, Takino T, Okada Y et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature (London) 1994; 370: 61–5.
  Article CAS Google Scholar
• Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Met Rev 1990; 9: 289–303.
  Article CAS Google Scholar
• Pulyaeva H, Bueno J, Polette M et al. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 1997; 15: 111–20.
  Article PubMed CAS Google Scholar
• Sato H, Seiki M. Membrane-type-matrix metalloproteinase. J Biochem 1996; 119: 209–15.
  PubMed CAS Google Scholar
• Sommers CL, Thompson EW, Torri J et al. Absence of cell adhesion molecule uvomorulin expression in invasive human breast cancer cell lines. Cell Growth Differentiation 1991; 2: 365–72.
  PubMed CAS Google Scholar
• Thompson EW, Paik S, Brunner N et al. Association of increased basement invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 1992; 150: 534–44.
  Article PubMed CAS Google Scholar
• Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat 1995; 154: 8–20.
  Article PubMed CAS Google Scholar
• Bae SN, Arand G, Azzam H et al. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat 1993; 24: 241–55.
  Article PubMed CAS Google Scholar
• Thompson EW, Torri J, Sabol M et al. Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metast 1994; 12: 181–94.
  Article CAS Google Scholar
• Giuncluglio D, Culty M, Fassina G et al. Invasive phenotype of MCF-10A cells over expressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer 1995; 63: 815–22.
  Google Scholar
• Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145–54.
  PubMed CAS Google Scholar
• Murphy G, Cockett MF, Ward RV et al. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and-2 and punctuated metalloproteinase (PUMP). Biochem J 1991; 277: 277–9.
  PubMed CAS Google Scholar
• Sires UI, Griffin GL, Brockelman TJ et al. Degradation of entactin by matrix metalloproteinases: Susceptibility to matrilysin and identification of cleavage sites. J Biol Chem 1993; 268: 2069–74.
  PubMed CAS Google Scholar
• Newell KJ, Witty JP, Rodgers WH et al. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994; 10: 199–206.
  PubMed CAS Google Scholar
• Kawano N, Osawa H, Ito T et al. Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin and trypsin(ogen) in lung neoplasms: an immmunohistochemical study. Hum Pathol 1997; 28: 613–22.
  Article PubMed CAS Google Scholar
• Rha S, Kim JH, Roh JK et al. Sequential production and activation of matrix metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res Treat 1997; 43: 175–81.
  Article PubMed CAS Google Scholar
• Wood M, Fudge K, Mohler JL, et al. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cells. Clin Exp Metastasis 1997; 15: 246–58.
  Article PubMed CAS Google Scholar
• Sugiura Y, Shimada H, Seeger RC et al. Matrix metalloproteinases-2 and-9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis. Cancer Res 1998; 58: 2209–1.
  PubMed CAS Google Scholar
• Nakajima M, Welch DR, Wynn DM et al. Serum and plasma Mr 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res 1993; 53: 5802–7.
  PubMed CAS Google Scholar
• Zucker S, Lysik RM, Zarrabi MH et al. Mr 92,000 type collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993; 53: 140–6.
  PubMed CAS Google Scholar
• Ueda Y, Imai K, Tsuchiya H et al. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol 1996; 148: 611–22.
  PubMed CAS Google Scholar
• Zeng ZS, Huang Y, Cohen AM et al. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996; 14: 3133–40.
  PubMed CAS Google Scholar
• Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci USA. 1994; 91: 4293–7.
  Article PubMed CAS Google Scholar
• Azzam HS, Arand GA, Lippman ME et al. MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J Natl Cancer Inst 1993; 85: 1758–64.
  PubMed CAS Google Scholar
• Yamamoto M, Mohanam S, Sawaya R et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996, 56: 384–92.
  PubMed CAS Google Scholar
• Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stomelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992; 267: 3581–4.
  PubMed CAS Google Scholar
• Fridman R, Toth M, Pena D et al. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 1995; 55: 2548–55.
  PubMed CAS Google Scholar
• Okada Y, Gonoji Y, Naka K et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT1080 human fibrosarcoma cells. J Biol Chem 1992; 267: 21712–9.
  PubMed CAS Google Scholar
• Menashi S, Fridman R, Desrevieres S et al. Regulation of 92 kDa gelatinase B activity in the extracellular matrix by tissue kallikrein. Ann NY Acad Sci 1994; 732: 466–8.
  PubMed CAS Google Scholar
• Atkinson SJ, Crabbe T, Cowell S et al. Intermolecular autocatalytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995; 270: 30479–85.
  Article PubMed CAS Google Scholar
• Overall CM, Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and PUMP-1 is accompanied by the tissue inhibitor of matrix metalloproteinases. J Biol Chem 1990; 265: 21141–51.
  PubMed CAS Google Scholar
• Strongin AY, Marmer BL, Grant GA et al. Plasma membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993; 268: 14033–9.
  PubMed CAS Google Scholar
• Brown PD, Bloxide RE, Stuart NSA et al. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small lung carcinoma. J Natl Cancer Inst 1993; 85: 574–8.
  PubMed CAS Google Scholar
• Azzam HS, Thompson EW. Collagen induced activation of the Mr 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res 1992; 52: 4540–4.
  PubMed CAS Google Scholar
• Strongin AY, Collier I, Bannikov G et al. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 1995; 270: 5331–8.
  Article PubMed CAS Google Scholar
• Brooks PC, Stromblad S, Sanders LC et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasion cells by interaction with integrin _αvβ_3. Cell 1996; 85: 683–93.
  Article PubMed CAS Google Scholar
• Deryugina EI, Bourdon MA, Jungwirth K et al. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer 2000; 86(1): 15–23.
  Article PubMed CAS Google Scholar